Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06133491 · ClinicalTrials.gov registry record

Open Label, 6-month Study for High Frequency and Chronic Migraine,

A clinical trial of Chronic Migraine, Headache, sponsored by Ki Health Partners..

Active
Registry status
20
Enrollment target
2
Study locations

NCT06133491 is a study of Chronic Migraine, Headache that is active but no longer recruiting, run by Ki Health Partners.. The registered enrollment target is 20 participants, below the 253-participant average among 4 other Chronic Migraine, Headache trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06133491, a study of Chronic Migraine, Headache, is active but no longer recruiting, sponsored by Ki Health Partners..

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

This is a prospective, multi-center, unblinded study in patients with migraine (≥ 8 MMDs/month) requiring preventive treatment. Enrolled patients will receive DAX administered subcutaneously using an established, published, legacy injection paradigm (referred to herein as the "standard paradigm"). The safety and efficacy outcome measures will be assessed at selected dosing segments during the 24-week treatment phase.

Conditions Studied

Chronic Migraine, Headache

Interventions

  • BIOLOGICAL Daxibotulinumtonix A

Study Locations (2)

California

  • The Los Angeles Headache Center - Los Angeles

Connecticut

  • New England Institute for Clinical Research - Stamford

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-10-18
Est. Completion 2024-12

Sponsor

Ki Health Partners.

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06133491

The ClinicalTrials.gov registry entry for NCT06133491 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 4 other Chronic Migraine, Headache trials with a reported enrollment target (92% lower). The listed sponsor is Ki Health Partners., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Migraine, Headache appearing as the primary indexed condition, and to 1 intervention - of which Daxibotulinumtonix A is the first listed.

NCT06133491 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Connecticut.

Frequently Asked Questions

What is clinical trial NCT06133491 about?

NCT06133491 is a clinical study titled "Open Label, 6-month Study for High Frequency and Chronic Migraine,". This is a prospective, multi-center, unblinded study in patients with migraine (≥ 8 MMDs/month) requiring preventive treatment. Enrolled patients will receive DAX administered subcutaneously using an established, published, legacy injection paradigm (referred to herein as the "standard paradigm"). T...

What is the current status of trial NCT06133491?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2023-10-18. Estimated completion is 2024-12.

What conditions does trial NCT06133491 study?

This clinical trial studies the following conditions: Chronic Migraine, Headache.

What interventions are being tested in trial NCT06133491?

The interventions under investigation include: Daxibotulinumtonix A (BIOLOGICAL).

Who is sponsoring clinical trial NCT06133491?

This trial is sponsored by Ki Health Partners., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06133491 being conducted?

This trial has 2 study locations across California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Migraine, Headache

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Migraine, Headache

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.